What You Ought to Know:
– Healthcare know-how chief DrFirst has joined forces with treatment adherence firm PatchRx to sort out a significant healthcare problem: treatment non-adherence.
– The strategic collaboration goals to enhance affected person well being outcomes and scale back healthcare prices related to sufferers not taking their medicines as prescribed.
The Drawback of Treatment Non-Adherence
In the US alone, treatment non-adherence is estimated to contribute to roughly 125,000 deaths and practically $250 billion in healthcare prices yearly. This highlights the essential want for options that guarantee sufferers are taking their medicines correctly.
Complete Affected person Treatment Adherence
DrFirst and PatchRx mix their respective strengths to supply a extra complete image of affected person treatment adherence. Right here’s the way it works:
- DrFirst’s Inhabitants Threat Administration Answer: This answer presents essentially the most correct and up-to-date treatment historical past for sufferers, together with medicines bought exterior conventional insurance coverage channels.
- PatchRx’s Sensible Tablet Bottle Expertise: PatchRx makes use of a patented, discreet sensible cap that matches on any commonplace capsule bottle. This cover gathers treatment utilization knowledge securely, offering beneficial insights for each sufferers and their care groups.
By offering a extra holistic view of treatment use, DrFirst and PatchRx empower care suppliers to ship extra focused and efficient care, in the end resulting in a more healthy inhabitants and a extra environment friendly healthcare system.
“Timing is all the pieces on the subject of efficient therapy of advanced situations,” stated G. Cameron Deemer, CEO of DrFirst. “Combining our complete prescription fill knowledge with distant monitoring knowledge from PatchRx will give suppliers the data they should determine sufferers who’re off schedule with their medicines and to intervene early to supply help and stop well being issues.”